Quartesian Partnership Gives Midsize CRO a Competitive Edge
CRO Gives Sponsors the Best of Both Worlds By Partnering with Quartesian The Challenge: Offer Midsize CRO Benefits With Large
Quartesian Continues Record Growth
Quartesian, a leading data CRO quickly becoming a clinical data services industry favorite, recently announced a second consecutive year of
Quartesian Gains Complete Access to Medidata Clinical Cloud
In exciting news for Quartesian and their clients, an agreement with Medidata will now provide complete access to the unified Medidata
Quartesian Partnership Empowers Catawba to Reduce TCO for Clients
CRO Drives Efficiencies in Ophthalmology, Dermatology, and Women’s Health Trials The Challenge: Maintaining High Quality While Reducing Budgets and Timelines
Quartesian Helps Large FSP Save 20% On Labor Costs
Data Management, SAS, and RAVE Resources Drive Scalability The Challenge: Going from 3 Vendors to 1 While Fueling Growth A
Quartesian Helps Top 5 Dermatology Company Accelerate Clinical Trials
Data Management and FSP Services Shave Weeks Off Startup Time The Challenge: Manual Processes Inflate Budgets and Timelines A top
Quartesian Helps Top 10 Generics Sponsor File First
Quartesian Overcomes Trial Obstacles to Help Move Taro to the Front of the Line The Challenge: Enrollment and Monitoring Delays
Quartesian Data Expertise Rescues Study By a Top 3 Generics CRO
How a Quartesian FSP Partnership Helped a Leading CRO Save the Day The Challenge: Enrollment and Database Challenges Threaten Study
Quartesian Featured in May 2017 Issue of Pharma Tech Outlook
If you take a look at the most recent issue of Pharma Tech Outlook, you’ll see a familiar face on the
Quartesian Expands Medidata Expertise and Partnership — From RAVE to TSDV
Over the past three years, Quartesian has seen a significant uptick in demand for Medidata RAVE skillsets. To add even
Quartesian Expands Global Footprint, Eyeing More Sites in 2017
Quartesian’s global footprint is integral to its success as the clinical data FSP of choice for pharmaceuticals, biotech companies, and
Quartesian Shattered Records in 2016
As pharmaceutical and biotech innovations continue to gather speed, the clinical research industry demands better models for producing high quality
